Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bugworks Research

Bugworks Research?uq=gJQ7UQwH
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$9M LATEST DEAL AMOUNT
17 INVESTORS
Description

Developer of drugs for the treatment of antibiotic resistant bacterial infections. The company discovers antibiotics for the treatment of antibiotic resistant bacterial infections using systems biology, structural biology and medicinal chemistry in order to reduce efflux mediated drug resistance.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States

+1 (818) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bugworks Research’s full profile, request a free trial.

Bugworks Research Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 13-Aug-2018 $9M 000.00 Completed Generating Revenue
4. Grant 27-Jul-2017 00.00 00.000 Completed Generating Revenue
3. Seed Round 20-Nov-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 19-Jul-2014 Completed Generating Revenue
1. Grant 04-Feb-2014 $2.4M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Bugworks Research Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Bugworks Research Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Acquipharma Other Minority 000 0000 000000 0
The University of Tokyo Edge Capital Venture Capital Minority 000 0000 000000 0
3one4 Capital Venture Capital Minority 000 0000 000000 0
Baxter Ventures Corporate Venture Capital Minority 000 0000 000000 0
CARB-X Government 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Bugworks Research Executive Team (7)

Name Title Board
Seat
Contact
Info
Anand Anandkumar Ph.D Co-Founder & Chief Executive Officer
V Balasubramanian Co-Founder, President, Research & Development, Executive Director
Santanu Datta Ph.D Co-Founder, Executive Director & Chief Scientific Officer
Shahul Hameed Vice President, Discovery

3 Former Executives

You’re viewing 4 of 7 executives. Get the full list »

Bugworks Research Board Members (1)

Name Representing Role Since Contact
Info
Atsushi Usami Ph.D The University of Tokyo Edge Capital Board Member 000 0000